Format

Send to

Choose Destination
See comment in PubMed Commons below
Infect Dis Clin North Am. 2007 Mar;21(1):219-39, x.

The future of HIV prevention: prospects for an effective anti-HIV microbicide.

Author information

1
International Partnership for Microbicides, Silver Spring, MD 20910, USA. jnuttall@ipm-microbicides.org

Abstract

Topical microbicides are self-administered products for prevention of HIV transmission, and they present one of the most promising strategies for combating the HIV-AIDS epidemic. The development of microbicides is a long and complicated process, with many hurdles that are unique to this class of product, including challenges in product design, in the conduct and design of clinical trials, and in obtaining licensure of a new class of products intended for use almost exclusively in developing countries. Once they have been registered, there are additional challenges to the marketing and distribution of microbicides. An overview of the types of microbicide currently in development, and a summary of the issues and the approaches being taken to address them, are provided.

PMID:
17502237
DOI:
10.1016/j.idc.2007.01.009
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center